BRGX Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume1.11K
Average Volume (3M)59.55K
Market Cap
$7.29M
Enterprise Value$10.18M
Total Cash (Recent Filing)$45.81K
Total Debt (Recent Filing)$2.17M
Price to Earnings (P/E)―
Beta0.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding971,575,200
10 Day Avg. Volume11,689
30 Day Avg. Volume59,554
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)-2.73
Price to Sales (P/S)6.68
P/FCF Ratio413.85
Enterprise Value/Market Cap1.40
Enterprise Value/Revenue5.77
Enterprise Value/Gross Profit7.04
Enterprise Value/Ebitda-30.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BRGX FAQ
What was BioRegenx’s price range in the past 12 months?
BioRegenx lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is BioRegenx’s market cap?
BioRegenx’s market cap is $7.29M.
When is BioRegenx’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioRegenx’s earnings last quarter?
BioRegenx released its earnings results on Oct 22, 2019. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is BioRegenx overvalued?
According to Wall Street analysts BioRegenx’s price is currently Overvalued.
Does BioRegenx pay dividends?
BioRegenx does not currently pay dividends.
What is BioRegenx’s EPS estimate?
BioRegenx’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioRegenx have?
BioRegenx has 971,575,200 shares outstanding.
What happened to BioRegenx’s price movement after its last earnings report?
BioRegenx reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of BioRegenx?
Currently, no hedge funds are holding shares in BRGX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BioRegenx
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform. In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.